medline.ch Respirationstrakt Neoplasie

	Evaluation of cerebrospinal fluid human epididymis protein 4 for leptomeningeal metastasis in non-small cell lung cancer: a prospective cohort study. BMC Cancer Lin YJ, He MY, Xie Y, Yin ZY, Lin XW, Hu LL. PMID: 42271303 [PubMed - as supplied by publisher]
	Bulk and single-cell transcriptomics reveal prognostic signatures of phosphoinositide metabolism in lung adenocarcinoma. Sci Rep Zhou L, Lei P, Luo Z, Xiao J, Chen Z. PMID: 42270842 [PubMed - as supplied by publisher]
	Quantitative silica dust exposure and lung cancer incidence in hard rock miners: 1.6 million person-years of follow-up in the Mining Master File cohort study. Occup Environ Med DeBono NL, Everest L, Berriault C, Nguyen L, Arrandale VH, Demers PA, Kirkham TL. PMID: 42270323 [PubMed - as supplied by publisher]
	GPNMB immunohistochemistry distinguishes diagnostically challenging cases of lymphangioleiomyomatosis from other mesenchymal neoplasms presenting with cystic lung metastases. Hum Pathol Ji SF, Law ME, Dawley JC, Manchen PJ, Butt YM, Smith ML, Tazelaar HD, Larsen BT. PMID: 42269880 [PubMed - as supplied by publisher]
	Targeting Inequities: Addressing Lung Cancer Care Challenges in Africa Through Drug Access, Radiotherapy, and Surgical Innovations. JCO Glob Oncol Obomanu E, Ugwu C, Megiso M, Verinumbe T, Jones C, Vanderpuye V, Hammad N. PMID: 42269135 [PubMed - in process]
	Robust Semi-Supervised CT Radiomics for Lung Cancer Prognosis: Cost-Effective Learning with Limited Labels and SHAP Interpretation. IEEE Trans Biomed Eng Salmanpour MR, Pouria AH, Falahati S, Taeb S, Mehrnia SS, Maghsudi M, Jouzdani AF, Oveisi M, Hacihaliloglu I, Rahmim A. PMID: 42268765 [PubMed - as supplied by publisher]
	Nutritional Indexes and Their Variations as Predictors of Atezolizumab Plus Chemotherapy Efficacy in Extensive-Stage Small Cell Lung Cancer: A Turkish Oncology Group Study. J Immunother Demircan NC, Özdemir M, Ball, Köse Baytemur N, Helvac, Akba, Efil SC, Sümbül AT, Çelebi A, Karakaya S, Kahraman S, Güven DC, Kutlu Y, I, , U, Nay, Uzun M, Gököz Do, Demirkaz, Demirci U, Selçukbiricik F, , Bayo, K, Bilici A, Hac, Karao, Tatl, Yumuk PF. PMID: 42267536 [PubMed - as supplied by publisher]
	Prognostic and Predict Value of Peripheral Blood Circulating Tumor Cells Programmed Death-Ligand 1 Expression and F-18-Fluorodeoxyglucose Metabolic Parameters in Patients With Advanced Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors. Cancer Med Sun M, Aikedan A, Rui Z, Ding E, Shen J. PMID: 42267455 [PubMed - in process]
	Lung cancer in never-smoking females: epidemiology, risk factors and screening. Front Public Health Ding Y, Tao H, Zhu C, Li H, Zhang Y, Du Y, Du L, Gong W, Wang L. PMID: 42267273 [PubMed - in process]
	Radon Exposure as an Occupational Hazard and Environmental Risk Factor for Lung Cancer in Utah: Assessment, Mitigation, and Policy Implications. J Registry Manag Daramola O. PMID: 42267114 [PubMed - in process]
	HHLA2 as an emerging immune checkpoint in lung cancer: linking EGFR signaling, macrophage polarization, and CD8(+) T-cell metabolic suppression. Front Immunol Wang J, Wang K, Hu Z, Hu X. PMID: 42266686 [PubMed - in process]
	Multi-omics profiling identifies ADAM9 as a key efferocytosis driver in lung adenocarcinoma. Front Immunol Lin G, Lin L, Zhao J, Chen G. PMID: 42266684 [PubMed - indexed for MEDLINE]
	Prognostic Effect of TTF-1 Expression and Histopathology in the Patients with Advanced Lung Adenocarcinoma Treated with Immunochemotherapy. Kobe J Med Sci Iwamoto N, Yamada J, Jimbo N, Yamasaki N, Hatakeyama Y, Kiriu T, Matsumura K, Katsurada M, Okuno K, Nakata K, Tachihara M. PMID: 42266151 [PubMed - indexed for MEDLINE]
	Combining Commercial Cancer Protein Biomarkers and Benign Fungal Antibodies Improves Diagnostic Accuracy in Pulmonary Nodules. Ann Surg Holmes HM, McGann KC, Chen SC, Welch C, Zou Y, Antic S, Forero YJ, Argaw SA, Chen H, Kaizer A, Baron A, Meguid R, Maldonado F, Deppen SA, Grogan EL. PMID: 42265763 [PubMed - as supplied by publisher]
	Multiomics integration prioritizes potential drug targets for lung cancer. Discov Oncol Meng P, Zhang Z, Ruan Z, Xu C. PMID: 42265473 [PubMed - as supplied by publisher]
	Observational study of predictors and outcomes of lung cancer in never-smokers in the UK (OLIVE): study protocol. BMJ Open Respir Res Naidu SB, Guvensen G, Wu H, Omar RZ, Menon U, Popat S, Moore DA, Soo Y, Bhamani A, Thakrar R, Ahmad T, Ppi Group O, Janes SM, Forster MD, Navani N. PMID: 42264884 [PubMed - in process]
	Minimally Invasive/Robotic Surgery for Lung Cancer. Surg Oncol Clin N Am Wheelwright M, Su KW, Krantz SB. PMID: 42264693 [PubMed - in process]
	STAGE II NON-SMALL CELL LUNG CANCER: UPFRONT SURGERY OR NEOADJUVANT CHEMOIMMUNOTHERAPY. Ann Thorac Surg Tajè R, Gallina FT, Spicer JD. PMID: 42264017 [PubMed - as supplied by publisher]
	TROP2 as a Promising Therapeutic Target in Lung Cancer: Current Clinical Trial Landscape and Future Directions. Pulm Pharmacol Ther Liu M, Luo R, Liu Y, Fan Y, Zhang J, Liu M. PMID: 42263842 [PubMed - as supplied by publisher]
	Palladium nanoparticles in lung cancer: Emerging strategies for diagnosis and therapeutic intervention. Pathol Res Pract Swarn S, Parmar V, Sharma SK, Saini V, Prajapati BG, Alsaidan OA, Alzarea SI, Kapoor DU. PMID: 42263463 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 160304

Seite 1 von 8016



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung